Literature DB >> 9240459

Nucleotide binding to autotaxin: crosslinking of bound substrate followed by lysC digestion identifies two labeled peptides.

T Clair1, H C Krutzsch, L A Liotta, M L Stracke.   

Abstract

Autotaxin (ATX) is a 125 kDa glycoprotein motility factor and exoenzyme which can catalyze the hydrolysis of either the alpha-beta or at the beta-gamma phosphodiester bond in ATP. Its motility stimulating activity requires an intact 5'-nucleotide phosphodiesterase (PDE) active site. Photolysis-dependent labeling of ATX with alpha-[32P]-8-N3-ATP, lysC digestion, and peptide HPLC resolved two radioactive fractions containing single peptides whose amino-terminal sequences were determined. Peptide A (T210FPNLYTLATG. . .) was derived from the PDE active site and peptide B (Y318GPFGPEMTNP. . .) was not previously known to be involved in any of the activities of ATX. The differential effect of NaCl concentration on the labeling of these two peptides, as well as on the two reaction types catalyzed by ATX, allows a classification of activities which predicts both the position of preferential peptide labeling by bound ATP and also the position of phosphodiester bond hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240459     DOI: 10.1006/bbrc.1997.6982

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells.

Authors:  Ji Heon Noh; So Yeon Ryu; Jung Woo Eun; Jaehwi Song; Young Min Ahn; Su Young Kim; Sug Hyung Lee; Won Sang Park; Nam Jin Yoo; Jung Young Lee; Shi Nae Lee; Suk Woo Nam
Journal:  Mol Cell Biochem       Date:  2006-04-07       Impact factor: 3.396

Review 2.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

3.  Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

Authors:  Laurens A van Meeteren; Volker Brinkmann; Jean Sébastien Saulnier-Blache; Kevin R Lynch; Wouter H Moolenaar
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.